Press release
GSK plc (NYSE: GSK) Investor Alert: Deadline in Lawsuit on April 7, 2025
A Deadline is coming up on April 7, 2025in the lawsuit for certain investors in GSK plc (NYSE: GSK) and GSK plc (NYSE: GSK) stockh
Investors who purchased shares of GSK plc (NYSE: GSK) have certain options and there are strict and short deadlines running. Deadline: April 7, 2025. GSK plc (NYSE: GSK) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges on behalf of purchasers of GSK plc (NYSE: GSK) common shares between February 5, 2020, and August 14, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 5, 2020, and August 14, 2022, the Defendants represented to investors that GSK removed Zantac from the market "[b]ased on information available at the time and correspondence with regulators," that GSK was "continuing with investigations into the potential source of NDMA", that the Defendants also assured investors that "GSK, the FDA, and the EMA [European Medicines Agency] have all independently concluded that there is no evidence of a causal association between ranitidine therapy and the development of cancer in patients," findings that were "consistent with other ranitidine data published prior to 2019", and that the Defendants claimed that they could not "quantify or reliably estimate the liability" GSK could face from Zantac-related legal proceedings.
Those who purchased shares of GSK plc (NYSE: GSK) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release GSK plc (NYSE: GSK) Investor Alert: Deadline in Lawsuit on April 7, 2025 here
News-ID: 3933980 • Views: …
More Releases from Shareholders Foundation, Inc.
Investor Alert: Lawsuit filed for Investors who lost money with shares of Blaize …
An investor, who purchased shares of Blaize Holdings, Inc. (NASDAQ: BZAI), filed a lawsuit over alleged violations of Federal Securities Laws by Blaize Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Blaize Holdings, Inc. (NASDAQ: BZAI), have certain options and for certain investors are short and strict deadlines running. Deadline: October 5, 2026. NASDAQ: BZAI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation Alert: Investors who hold shares of Commvault Systems, Inc. (NASDA …
An investigation was announced for long-term investors in shares of Commvault Systems, Inc. (NASDAQ: CVLT) concerning potential breaches of fiduciary duties by certain directors of Commvault Systems, Inc.
Investors who are current long term investors in Commvault Systems, Inc. (NASDAQ: CVLT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Wise Group plc (NASDAQ: WSE) Investor Alert: Lawsuit seeks to recover Investor L …
An investor, who purchased shares of Wise Group plc (NASDAQ: WSE), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by Wise Group plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Wise Group plc (NASDAQ: WSE) have certain options and for certain investors are short and strict deadlines running. Deadline: September 29, 2026. NASDAQ: WSE investors should contact the Shareholders…
NYSE: GPK Investigation Alert: Investors who hold shares of Graphic Packaging Ho …
An investigation was announced for long-term investors in shares of Graphic Packaging Holding Company (NYSE: GPK) concerning potential breaches of fiduciary duties by certain directors of Graphic Packaging Holding Company.
Investors who are current long term investors in Graphic Packaging Holding Company (NYSE: GPK) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long…
More Releases for GSK
Lawsuit filed for Investors in shares of GSK plc (NYSE: GSK) over alleged Securi …
An investor, who purchased shares of GSK plc (NYSE: GSK), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by GSK plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of GSK plc (NYSE: GSK) have certain options and for certain investors are short and strict deadlines running. Deadline: April 7, 2025. NYSE: GSK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Chronic Refractory Cough Pipeline 2024 | GSK, Trevi Therapeutics
DelveInsight's, "Chronic Refractory Cough Pipeline Insight 2024" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Chronic Refractory Cough pipeline landscape. It covers the Chronic Refractory Cough pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Refractory Cough therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover the latest…
Zoster Vaccine Live Market | GSK, Merck, ,
The global zoster vaccine live market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the zoster vaccine live market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Investigation announced for Investors in GSK plc (NYSE: GSK) over potential Wron …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at GSK plc.
Investors who purchased shares of GSK plc (NYSE: GSK) and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain GSK directors breached their fiduciary duties and caused damage to the company and its shareholders.
United Kingdom based GSK plc, together with its…
Investigation announced for Investors in shares of GSK plc (NYSE: GSK) over poss …
An investigation was announced for investors of GSK plc (NYSE: GSK) shares over potential securities laws violations by GSK plc.
Investors who purchased shares of GSK plc (NYSE: GSK), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by GSK plc regarding its business, its prospects and its operations were materially…
Vaccines Industry Market Growth Prospects And Outlook 2022-2027| GSK, Sanofi, Me …
The Vaccines market outlook looks extremely promising is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain, future roadmaps and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report.
Top Companies in the Global…
